Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 43Neoplasms 24Motor Activity 12Pain, Postoperative 9Colorectal Neoplasms 9Stomach Neoplasms 8Lung Neoplasms 8Fatigue 7Anxiety Disorders 6Pain 5Carcinoma, Hepatocellular 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Leukemia, Myeloid, Acute 4Depression 4Colonic Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Stomatitis 3Squamous Cell Carcinoma of Head and Neck 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Malnutrition 3Liver Neoplasms 3Head and Neck Neoplasms 3Agnosia 3Vomiting 2Urinary Incontinence 2

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Control Groups × Clear all
NCT00813332 2010-01-25

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Simcere Pharmaceutical Co., Ltd

Phase 4 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡